Palvella Therapeutics (PVLA) EPS (Basic) (2013 - 2026)
Palvella Therapeutics' (PVLA) quarterly EPS (Basic) came in at -$1.2 in Q1 2026, down 62.14% year-on-year from -$3.18 in Q1 2025, and down 6.1% on a QoQ basis from -$1.14 in Q4 2025.
Palvella Therapeutics (PVLA) EPS (Basic) (2013 - 2026) Analysis & Trends
Palvella Therapeutics (PVLA) has 14 years of EPS (Basic) data on file, last reported at -$1.2 in Q1 2026.
- On a quarterly basis, EPS (Basic) fell 62.14% year-over-year to -$1.2 in Q1 2026; TTM through Mar 2026 was -$3.77, a 81.51% decrease from a year earlier, with the FY2025 full-year figure at -$3.71, up 52.59% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$1.2, down from -$1.14 in the prior quarter.
- Over the last five years, EPS (Basic) for PVLA reached as high as $13.31 in Q4 2023 and fell as low as -$17.19 in Q1 2023.
- Historically, EPS (Basic) has averaged -$4.67 across 5 years, with a median of -$2.21 in 2024.
- Across the five-year window, EPS (Basic) jumped 200.18% in 2023 and plunged 335.57% in 2024, its largest moves.
- Year by year, EPS (Basic) stood at -$13.29 in 2022, then soared by 200.18% to $13.31 in 2023, then tumbled by 111.37% to -$1.51 in 2024, then gained by 24.96% to -$1.14 in 2025, then decreased by 6.1% to -$1.2 in 2026.
- Per Business Quant data, the three most recent EPS (Basic) figures were -$1.2 in Q1 2026, -$1.14 in Q4 2025, and -$1.03 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Palvella Therapeutics | 1.84 Bn | 1.57 Bn | - | -1.20 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.20 |
| Dec 31, 2025 | -1.14 |
| Sep 30, 2025 | -1.03 |
| Jun 30, 2025 | -0.86 |
| Mar 31, 2025 | -0.74 |
| Dec 31, 2024 | -1.51 |
| Sep 30, 2024 | -5.28 |
| Jun 30, 2024 | -3.36 |
| Mar 31, 2024 | -2.21 |
| Dec 31, 2023 | 13.31 |
| Sep 30, 2023 | -9.96 |
| Jun 30, 2023 | 1.43 |
| Mar 31, 2023 | -17.19 |
| Dec 31, 2022 | -13.29 |
| Sep 30, 2022 | -13.62 |
| Jun 30, 2022 | -13.95 |
| Mar 31, 2022 | -8.74 |
| Dec 31, 2021 | -14.50 |
| Sep 30, 2021 | -23.16 |
| Jun 30, 2021 | -22.44 |